Last 44.89 TWD
Change Today -0.21 / -0.47%
Volume 66.6K
4159 On Other Exchanges
Symbol
Exchange
Taiwan
As of 12:53 AM 01/30/15 All times are local (Market data is delayed by at least 15 minutes).

fountain biopharma inc (4159) Snapshot

Open
45.03
Previous Close
45.10
Day High
45.64
Day Low
44.19
52 Week High
05/16/14 - 119.87
52 Week Low
01/21/15 - 43.90
Market Cap
6.8B
Average Volume 10 Days
110.7K
EPS TTM
-1.45
Shares Outstanding
150.7M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for FOUNTAIN BIOPHARMA INC (4159)

Related News

No related news articles were found.

fountain biopharma inc (4159) Related Businessweek News

No Related Businessweek News Found

fountain biopharma inc (4159) Details

Fountain Biopharma Inc. develops humanized monoclonal antibodies for the treatment of allergic disorders and cancers. Its products under preclinical stage include FB704A for the treatment of rheumatoid arthritis; FB121 for treating AIDS; and FB811 used for the treatment of non-hodgkin’s lymphoma. The company’s products under Phase I stage comprise FB825 and FB317 for treating allergic asthma. The company was founded in 2010 and is headquartered in Taipei, Taiwan.

Founded in 2010

fountain biopharma inc (4159) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

fountain biopharma inc (4159) Key Developments

Fountain Biopharma Inc., Annual General Meeting, Jun 27, 2014

Fountain Biopharma Inc., Annual General Meeting, Jun 27, 2014.

Fountain Biopharma Inc. Presents at BIO International Convention, Jun-24-2014 04:45 PM

Fountain Biopharma Inc. Presents at BIO International Convention, Jun-24-2014 04:45 PM. Venue: San Diego Convention Center, San Diego, California, United States.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4159:TT 44.89 TWD -0.21

4159 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 4159.
View Industry Companies
 

Industry Analysis

4159

Industry Average

Valuation 4159 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 13,182.7x
Price/Book 3.5x
Price/Cash Flow NM Not Meaningful
TEV/Sales 12,217.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact FOUNTAIN BIOPHARMA INC, please visit www.fountainmab.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.